Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients

BackgroundPatients with hepatocellular carcinoma (HCC) with main portal vein tumor thrombus (mPVTT) have poor prognosis. Promising systemic therapies, such as target therapies, have limited benefits. The purpose of this study is to retrospectively evaluate the benefits of conventional TACE (c-TACE)...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Jing-huan Li, Xin Yin, Wen-shuai Fan, Lan Zhang, Rong-xin Chen, Yi Chen, Li-xin Li, Ning-ling Ge, Yu-hong Gan, Yan-hong Wang, Zheng-gang Ren
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2021-08-01
Serier:	Frontiers in Oncology
Fag:	hepatocellular carcinoma (HCC) portal vein tumor thrombus (PVTT) transarterial chemoembolization (TACE) overall survival (OS) prognosis model
Online adgang:	https://www.frontiersin.org/articles/10.3389/fonc.2021.671171/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!